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Abstract
Background: During developmental and adult neurogenesis, doublecortin is an early neuronal
marker expressed when neural stem cells assume a neuronal cell fate. To understand mechanisms
involved in early processes of neuronal fate decision, we investigated cell lines for their capacity to
induce expression of doublecortin upon neuronal differentiation and develop in vitro reporter
models using doublecortin promoter sequences.
Results: Among various cell lines investigated, the human teratocarcinoma cell line NTERA-2 was
found to fulfill our criteria. Following induction of differentiation using retinoic acid treatment, we
observed a 16-fold increase in doublecortin mRNA expression, as well as strong induction of
doublecortin polypeptide expression. The acquisition of a neuronal precursor phenotype was also
substantiated by the establishment of a multipolar neuronal morphology and expression of
additional neuronal markers, such as Map2, βIII-tubulin and neuron-specific enolase. Moreover,
stable transfection in NTERA-2 cells of reporter constructs encoding fluorescent or luminescent
genes under the control of the doublecortin promoter allowed us to directly detect induction of
neuronal differentiation in cell culture, such as following retinoic acid treatment or mouse Ngn2
transient overexpression.
Conclusion: Induction of doublecortin expression in differentiating NTERA-2 cells suggests that
these cells accurately recapitulate some of the very early events of neuronal determination. Hence,
the use of reporter genes under the control of the doublecortin promoter in NTERA-2 cells will
help us to investigate factors involved early in the course of neuronal differentiation processes.
Moreover the ease to detect the induction of a neuronal program in this model will permit to
perform high throughput screening for compounds acting on the early neuronal differentiation
mechanisms.
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Background
Neurogenesis relies on a pool of proliferative neural stem
cells differentiating into new neurons following induction
of a neurogenic gene expression program. The whole mat-
uration process from the multipotent neural stem cells
into functional mature neurons involves several factors
that orchestrate each step in an intricate continuum. A key
event of neurogenesis is the neuronal commitment of
multipotent neural stem cells, i.e. the time point at which
cells lose their capacity to generate neurons as well as glia,
and become restricted to the generation of new neurons.
Doublecortin (DCX) constitutes a marker for neuronal
precursors throughout developmental and adult neuro-
genesis [1-4]. We demonstrated that DCX was expressed
very early in newly generated neuronal precursors of the
adult CNS [3]. Recently, a cortical subpopulation of
multipotent DCX- NG2-expressing cells was reported in
the adult CNS [5]. However, the identity of these cells and
how they related to neurogenic processes has currently
not been elucidated.
Although expression of DCX is well documented in neu-
ronal precursors in vivo and in primary cell cultures, a cell
line inducing sustained expression of DCX upon differen-
tiation needed so far to be identified. The identification of
such an in vitro model reproducing the early phases of
neuronal determination would greatly accelerate the
study of factors influencing neurogenesis. NTERA-2 cells
have been previously reported to induce a complex neuro-
nal differentiation program in response to retinoic acid
(see for examples [6-8]). Based on the induction of DCX
and DCX-driven reporter constructs upon differentiation,
we further substantiated evidences establishing the
NTERA-2 cell line as an appropriate and convenient in
vitro model to study early steps of neuronal differentiation
and factors acting on this process during development
and in the adult CNS.
Results
Morphological changes in response to retinoic acid 
treatment
Five neuronal-like cell lines were tested for their capacity
to mimic early events of neuronal determination and dif-
ferentiation taking place during development or adult
neurogenesis: D283 medulloblastoma (human medul-
loblastoma), DAOY (human medulloblastoma), NTERA-
2 (human teratocarcinoma), PC-12 (rat pheochromacy-
toma), SK-N-SH (human teratocarcinoma). Additionally,
HeLa cells (human adenocarcinoma) were chosen as non-
neuronal control cell line. To differentiate cell lines
towards a neuronal phenotype, retinoic acid (10 μM) was
added to the cultures.
Figure 1 shows the morphological appearance of cell lines
in response to retinoic acid treatment. Hence, after 28
days of differentiation, NTERA-2 cells morphology
showed pronounced reorganization characterized by the
formation of cell clusters and processes creating a com-
plex cellular network (Fig 1A and 1G). In addition, D283
cell lines adopted a flattened morphology and showed
increased cell death during differentiation treatment
Morphological changes in response to retinoic acid treatment Figure 1
Morphological changes in response to retinoic acid treatment. Cell lines grown in standard conditions (A-F) or 
treated with retinoic acid (G-L). Only NTERA-2 cells (A vs. G) and D283 cells (B vs. H) showed a morphological response to 
retinoic acid. PC12 cells treated with NGF developed a complex network of cellular processes (I inset). Scale bar in L = 100 
μm.BMC Neuroscience 2008, 9:31 http://www.biomedcentral.com/1471-2202/9/31
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(Fig 1B and 1H). Finally, minor or no morphological
responses could be detected for DAOY, HeLa, PC-12 or
SK-N-SH cells following retinoic acid treatment.
PC-12 cells are known to undergo neuronal morphologi-
cal differentiation in the presence of nerve growth factor
(NGF). To confirm the potential of our PC-12 cultures to
adopt a neuronal morphology upon differentiation, we
maintained them four weeks in the presence of NGF (50
ng/ml). As previously described, PC12 cells underwent an
extensive process outgrowth in response to NGF (Fig 1I
inset).
Induction of early neuronal marker expression in response 
to retinoic acid
To examine if morphological changes observed in
response to retinoic acid correlated with expression of
genes induced during neuronal early differentiation,
expression of DCX was assessed by immunocytochemis-
try. Figure 2(A–F) shows the absence of DCX expression in
undifferentiated cells from the six cell lines investigated.
Following differentiation however, robust expression of
DCX could be detected in a large fraction of the NTERA-2
cells, especially those forming the cell clusters (Fig 2G).
Expression could also be detected at a low level in differ-
entiated D283 cells (Fig 2H). Moreover, most neuronal-
differentiated NTERA-2 cells expressing DCX also induced
expression of the neuronal-specific microtubule-binding
protein Map2, hence revealing some degrees of neuronal
maturation (Fig 2G). In contrast, only a few DCX-express-
ing differentiated D283 cells did express Map2. Finally,
Map2 expression could be detected in differentiated PC12
cells and rarely in HeLa cells as well, however, DCX
expression could never be detected in these cell lines.
Induction of DCX expression in response to retinoic acid
Induction of DCX mRNA expression following retinoic
acid treatment was further quantified in total RNA from
each cell lines either in a proliferative state or following
differentiation. In agreement with observation made by
immunocytochemistry, undifferentiated cell lines did not
express DCX, or did only in trace amounts (Fig 2M). On
the other hand, following retinoic acid-induced differen-
tiation, levels of DCX mRNA in NTERA-2 cells were
increased approximately 16 times. Likewise, DCX mRNA
levels were approximately 12 times more elevated in dif-
ferentiated D283 cells then in the non-differentiated cells.
The absolute DCX mRNA levels in D283 cells, however,
were roughly half of those found in NTERA-2 cells.
Finally, DCX mRNA expression was not detected in the
other differentiated cell lines.
To examine the induction of DCX expression in respect to
other neuronal genes, we followed the expression of
NeuroD1, DCX and neuron-specific enolase (NSE) at var-
ious differentiation time points, i.e. proliferative state and
following 3 days, 7 days, 14 days, 21 days and 28 days of
retinoic acid treatment. As shown in figure 2O, retinoic
acid treatment rapidly and transiently induced high levels
of NeuroD1 expression, a neurogenic transcription factor
[9]. As NeuroD1 expression declined between day 14 and
21 of differentiation, expression of DCX mRNA was
induced and further increased until the last time point at
28 days. Finally, expression of NSE mRNA, an enzyme
found in mature neurons [10], was induced only after the
third week of differentiation. Hence, our differentiating
NTERA-2 cultures expressed a key neurogenic factor, a
neuronal precursor marker, and a mature neuronal
marker in successive phases. This suggests that differentia-
tion of NTERA-2 cells mimicked faithfully the various
phases of the neuronal determination and differentiation
program also induced in neural stem cells.
Western blot analysis substantiated the induction of DCX
expression measured at the mRNA level. Whereas, very
low levels of DCX protein expression could be measured
in proliferating NTERA-2 cells, strong expression could be
detected in differentiated NTERA-2 cells (Fig 2N). In addi-
tion, low levels of DCX protein expression could be
detected in differentiated D283 cells (Fig 2N), in agree-
ment with the lower abundance of DCX mRNA measured
in these cells (Fig 2M). The presence of DCX protein could
not be documented in the other cells lines, notwithstand-
ing their differentiation status.
Expression of several neural markers in differentiating
NTERA-2 cells was scrutinized in more details by immu-
nocytochemistry at various time points. As shown in fig-
ure 2P, within the first 7 days of exposition to retinoic
acid, the expression A2B5, a neural cell surface antigen,
was induced in a large proportion of the cells, in agree-
ment with previous report [8]. Expression of nestin, an
intermediate filament expressed in neural stem cells, was
found in a high percentage of NTERA-2 cells at all time
points. Nestin expression, however, decreased slowly dur-
ing the course of differentiation. In contrast, NG2, an anti-
gen present on the cell surface of glial precursors, could
not be detected in our NTERA-2 cultures at any time point.
Expression of neuronal markers became significant after 3
weeks of differentiation. Hence, expression of βIII-tubu-
lin, DCX and Map2 were strongly induced and following
4 weeks of retinoic acid treatment, was found in more
then 90% of the cells present in our NTERA-2 cultures.
Expression of GFAP was detected in a minor fraction of
the NTERA-2 cells at every time point. Finally, expression
of NeuN, a marker found in more mature neurons, could
not be detected using our differentiation paradigm.BMC Neuroscience 2008, 9:31 http://www.biomedcentral.com/1471-2202/9/31
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In vitro model of neuronal determination
This capacity of differentiating NTERA-2 cells to induce
expression of the DCX gene was further exploited to estab-
lish an in vitro reporter system for neuronal early differen-
tiation events. We recently reported that a genomic
fragment of 3,5 kb of the human DCX gene drove expres-
sion of reporter genes in neuronal precursors and young
neurons in vitro and in vivo [11,12]. We therefore gener-
ated stable NTERA-2 cell lines bearing the EGFP or the
firefly luciferase reporter gene under the control of the
DCX promoter sequences (NTERA-2DCX-EGFP and NTERA-
2DCX-luci). In parallel, we also generated transfected HeLa
Induction of DCX expression in response to retinoic acid treatment Figure 2
Induction of DCX expression in response to retinoic acid treatment. Cell lines grown in standard conditions did not 
express DCX (green) (A-F), whereas following retinoic acid treatment NTERA-2 cells (G) and to a lower extent D283 cells 
(H) expressed DCX. The presence of Map2 (red) could also be detected in most DCX-expressing NTERA-2. Strong induction 
of DCX mRNA expression (M) and protein expression (N) were also detected in NTERA-2 cultures and to a lower level in 
D283 cultures following retinoic acid treatment. Treatment of PC12 with retinoic acid or NGF did not result in an induction of 
DCX protein expression. O) In response to retinoic acid, differentiation of NTERA-2 cells resulted in the successive induction 
of NeuroD1, DCX and NSE mRNAs expression. P) Immunocytochemistry on retinoic acid-treated NTERA-2 cultures 
revealed an early induction of A2B5 expression, followed by the induction of the neuronal markers βIII-tubulin, DCX and 
Map2. GFAP-expressing cells remained a minor fraction within the cultures.BMC Neuroscience 2008, 9:31 http://www.biomedcentral.com/1471-2202/9/31
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cell lines (HeLaDCX-EGFP and HeLaDCX-Luci) as non-neuro-
nal controls. Integration of the reporter construct was con-
firmed by PCR on the genomic DNA (data not shown).
Whereas undifferentiated NTERA-2DCX-EGFP and HeLaDCX-
EGFP did not express the EGFP reporter, retinoic acid treat-
ment strongly and specifically induced the expression of
EGFP in the NTERA-2DCX-EGFP cells but not in the HeLaDCX-
EGFP cells (Fig 3A–H). Immunocytochemistry further con-
firmed that EGFP-expressing cells also expressed DCX,
and frequently Map2 as well (Fig 3I–L).
The induction of the reporter gene in differentiating
NTERA-2 cells was examined at the mRNA and protein
levels. In agreement with the strong induction of the
endogenous DCX mRNA expression following differenti-
ation of NTERA-2DCX-EGFP cells, expression of the EGFP
reporter mRNA was observed to be strongly induced (Fig
3M). In contrast, HeLaDCX-EGFP did not upregulated the
expression of the EGFP reporter in response to retinoic
acid treatment. The potent induction of the reporter's
expression in NTERA-2 cells could also be documented by
western blotting (Fig 3N). Again, as expected from the
mRNA measurements, expression of the reporter was not
induced in HeLaDCX-EGFP cells, underscoring the neuronal
specificity of the reporter system.
Neurogenin 1 and neurogenin 2 (Ngn2) are transcription
factors of the basic helix-loop-helix (bHLH) family
expressed in the earliest steps of mammalian cortical neu-
rogenesis. They initiate a cascade of gene activation lead-
ing to the expression of terminal neuronal differentiation
genes [13,14]. It was recently reported that mouse Ngn2
could bind directly on the DCX promoter and activate it
[15]. The capacity of our reporter system to respond to
neurogenic factors was tested using a mouse Ngn2-encod-
ing vector to transiently transfect the NTERA-2DCX-luci cells.
HeLaDCX-Luci cell were used in parallel as a non-neuronal
control. As shown in figure 3O, brief expression of mouse
Ngn2 for as little as four days sufficed to activate DCX-
promoter driven expression of the luciferase reporter gene
in NTERA-2 cells, but not in HeLa cells.
Discussion
Over the last few years, DCX became an established
marker for neuronal determination and neurogenesis
[4,12,16]. In differentiating neural stem cells, either in vivo
or in vitro, expression of DCX can be detected upon induc-
tion of neuronal differentiation. To date however, no
established neural cell line was shown to have the capacity
to up-regulate DCX upon differentiation. In this report,
we show that NTERA-2 cells in conjunction with DCX
reporter constructs constitute an attractive model for the
study of early phases of neuronal differentiation occurring
during developmental and adult neurogenesis. Although,
ultimate validation of factors acting on neuronal differen-
tiation would need to be performed on primary cells,
there was a need for such an in vitro system behaving as a
simple neuronal differentiation model.
In contrast to other neural cell lines tested, such as PC12
cells, NTERA-2 and D283 cells could induce expression of
DCX mRNA in response to retinoic acid exposure, a treat-
ment known to induce a strong neurogenic response (for
example Guan et al. [17]). At the protein level however,
only differentiated NTERA-2 cells showed significant DCX
expression. Expression of DCX in NTERA-2 cells was asso-
ciated with the establishment of a neuronal morphology,
as well as with the expression of other neuronal-specific
markers, such as Map2 and NSE.
DCX expression occurs very early during the neuronal
determination/differentiation process, possibly due to the
direct binding of the bHLH transcription factors such as
Ngn2 on the DCX promoter [15]. Hence, it appears that
differentiating NTERA-2 cells can mimic neural stem cells
in the early phase of neuronal differentiation. Supporting
data also come from a recent gene profiling of NTERA-2
cells treated with retinoic acid. The latter revealed an
expression pattern compatible with early neuronal phe-
notypes found in the posterior hindbrain and other pos-
terior CNS regions [18]. Therefore, NTERA-2 cells appear
to be well suited to be used as an in vitro model to study
the early events of neuronal determination/differentiation
and the factors influencing it.
In addition, we showed that genetically modified NTERA-
2 cells bearing reporter genes under the control of the
human DCX promoter constitute a simple and valuable
tool to study factors acting on neuronal determination
and early differentiation. We have previously demon-
strated that DCX promoter-based expression vectors can
drive expression of reporter genes in neuronal precursors
and young neurons, both in vitro and in vivo [11,12]. The
fact that reporter expression was not induced in HeLa cells
further supports the evidence that expression of DCX pro-
moter-based construct in NTERA-2 cells accurately reflects
the induction of a complex genetic program similar to the
early phase of neural stem cells differentiation into neu-
rons, and not merely a cis-action on the DCX promoter.
Conclusion
We could demonstrate in this report that expression of
DCX and DCX promoter-driven reporters occurred in
NTERA-2 cells upon induction of neuronal differentia-
tion. Through this new and simple reporter system tool, it
will be possible to analyze early events of neuronal deter-
mination and differentiation such as occurring during
development and adult neurogenesis and identified new
neurons directly in statu nascendi. Moreover, this cultureBMC Neuroscience 2008, 9:31 http://www.biomedcentral.com/1471-2202/9/31
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Activation of DCX-promoter-reporter constructs in differentiating NTERA-2 cells Figure 3
Activation of DCX-promoter-reporter constructs in differentiating NTERA-2 cells. Upon differentiation using 
retinoic acid, NTERA-2DCX-EGFP clones (B and F), but not the HeLaDCX-EGFP clones, could induce the expression of the DCX-
promoter-EGFP reporter (A-H). NTERA-2DCX-EGFP cells inducing the expression of EGFP upon retinoic acid treatment (I), also 
expressed DCX (J) and frequently Map2 (K). Parallel upregulation of the EGFP reporter and DCX mRNAs (M) and proteins 
(N) upon retinoic acid differentiation could also be detected in NTERA-2 clones, but not in HeLa clones. Induction of a neuro-
genic differentiation program following transient transfection of mouse Ngn2 also resulted in a significant induction of DCX-
promoter-luciferase reporter in NTERA-2 clones, but not in HeLa clones (O).BMC Neuroscience 2008, 9:31 http://www.biomedcentral.com/1471-2202/9/31
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model also provides a rapid screening method for mole-
cules influencing the early process of neuronal differenti-
ation.
Methods
Cell cultures
Cells were maintained in a humidified incubator at 37°C
under an atmosphere containing 5% of CO2. HeLa, SK-N-
SH, DAOY and D283 medulloblastoma cells were culti-
vated in MEM(Eagle) with Earle's BSS, supplemented with
10% (v/v) fetal calf serum, 2 mM L-glutamine, 1 mM
sodium-bicarbonate, 0.1 mM non-essential amino acids,
100 U/ml Penicillin, 0.1 mg/ml Streptomycin. PC-12
were cultivated in RPMI 1640, supplemented with 10%
horse serum, 5% (v/v) fetal calf serum, 100 U/ml Penicil-
lin, 0.1 mg/ml Streptomycin, 2 mM L-glutamine. Finally,
NTERA-2 cells were maintained in DMEM, supplemented
with 10% (v/v) fetal calf serum, 4 mM L-glutamine, 4.5 g/
l Glucose, 100 U/ml Penicillin, 0.1 mg/ml Streptomycin,
1.5 g/l sodium-bicarbonate.
Cell differentiation
Cells were plated in a T75 culture flask at a density of 1.5
× 104 cells/cm2 in their corresponding media. For the dif-
ferentiation of D283 and PC-12 cell lines, the culture
flasks were coated with poly-ornithine (250 μg/ml) to
increase their adherence. One day after seeding, the differ-
entiation was initiated according to a differentiation pro-
tocol adapted from [7]. Differentiation was induced by
the addition of 10 μM of retinoic acid in the culture
media. Cells were maintained under these condition for a
period of 2 weeks, during which medium was replaced
every 3 days. Thereafter, cells were further cultivated for 2
weeks in their designated medium in absence of retinoic
acid. Retinoic acid treatment was previously reported to
remodel the genetic program of PC12 cells [19]. Neverthe-
less, a standard differentiation protocol for the PC12 cells
using 50 ng/ml nerve growth factor (NGF) in the culture
medium was also applied to confirm their capacity to dif-
ferentiate into neuron-like cells [20,21].
Cell transfections
For stable transfection, cells were plated one day before
transfection at a density of 1.5 × 105 cells/cm2 in a T75 cul-
ture flask. Vectors encoding the EGFP reporter gene, or the
firefly luciferase reporter gene, driven by the human DCX
promoter [12] where transfected using Metafectene (Bion-
tex Laboratories, Munich) according to manufacturer's
guidelines. Selection of transfected cells began 3 days after
transfection using Geneticin (250 μg/ml for HeLa and 300
μg/ml for NTERA-2). After 4 weeks under selection condi-
tions, stable transfected single cells were FACS sorted into
96 wells/plate to establish clonal cultures. In the stably
transfected clones, integration of reporter genes was con-
firmed by PCR on genomic DNA (EGFP-fow GCT GAC
CCT GAA GTT CAT CTG, EGFP-rev GGA CTT GAA GAA
GTC GTG CTG, Luciferase-fow TCA AAG AGG CGA ACT
GTG TG and Luciferase-rev TTT TCC GTC ATC GTC TTT
CC, beta-actin-fow AGC CAT GTA CGT AGC CAT CC,
beta-actin-rev CTC TCA GCT GTG GTG GTG AA). Vectors
used for transfection served as PCR control. Non-differen-
tiated cells expressing the EGFP reporter gene constitu-
tively, as a consequence of an insertion artifact for
example, were excluded.
Transcription factor transfection
To induce the neuronal differentiation, a vector encoding
the complete mouse Ngn2-coding sequence, from ATG to
the stop codon, flanked with a Myc tag was transfected
using Metafectene (Biontex Laboratories, Munich). We
used the bicistronic expression vector pIRES2-DsRed-
Express (Clontech) to drive the expression of Ngn2 under
the control of the CMV promoter. As control, we used the
empty vector pIRES2-DsRed-Express, devoid of Ngn2. On
the following day, transfected cell lines were plated in a 96
wells/plate at a density of 5 × 104 cells/well in triplicates
in their respective culture media without retinoic acid.
Four days after transfection, cells were processed to meas-
ure the firefly luciferase activity using the Luciferase Assay
System (Promega). Luciferase activities were reported in
arbitrary units, with the activities measured in NTERA-2
cells transfected with the empty vector representing the
reference (100%).
Expression analysis
Gene expression analysis was performed via quantitative
RT-PCR on total cDNAs isolated from undifferentiated
and differentiated cell cultures. RNAs were isolated using
the RNeasy-Kit (Qiagen, Hilden) and cDNAs were synthe-
sized using the RETROscript kit (Ambion, Austin, Texas,
USA). Quantitative detection of EGFP transcription prod-
uct was performed using a Rotor-Gene 3000 real-time
PCR apparatus (Corbett Research, Mortlake, Sydney, Aus-
tralia) and SYBR green master mix (Brilliant SYBR Green,
Stratagen). Signals obtained for the EGFP were normal-
ized on the levels of rRNA 15S (RETROscript kit,
Ambion). Expression levels are represented as EGFP/rRNA
15S ratio.
For the analysis of neuronal gene expression at various
time points of differentiation, total RNAs were extracted
from cultures using Tri Reagent (Sigma) according to the
manufacturer's protocol. Total RNAs were further purified
using the SV Total RNA Isolation System (Promega).
Reverse transcription was performed using the Reverse
Transcription System (Promega) and controls for each
sample were also generated by omitting the reverse tran-
scriptase from the reaction. Real-time PCR was realized
using SYBR Green QPCR Master Mix (Stratagen) and a
Mx3005P thermocycler (Stratagen). Measurements wereBMC Neuroscience 2008, 9:31 http://www.biomedcentral.com/1471-2202/9/31
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normalized on the β-actin mRNA levels and represented
for each gene relative to its maximal expression. The fol-
lowing oligos were used: β-actin fow AGC CAT GTA CGT
AGC CAT CC; β-actin rev CTC TCA GCT GTG GTG GTG
AA; EGFP fow GCT GAC CCT GAA GTT CAT CTG; EGFP
rev GGA CTT GAA GAA GTC GTG CTG; DCX fow GGA
AGG GGA AAG CTA TGT CTG; DCX rev TTG CTG CTA
GCC AAG GAC TG; NeuroD1 fow CCA AAA AGA AGA
AGA TGA CTA AGG; NeuroD1 rev AGC TGT CCA TGG
TAC CGT AA [8]; NSE fow ATC GCG CCA GCC CTC ATC
AGC; NSE rev TTT TCC GTG TAG CCA GCC TTG TCG [8].
Protein expression was analyzed on homogenate derived
from non-differentiated or differentiated cultures. Cells
were lyzed in SUB buffer (0.5% w/v SDS, 8 M Urea, 2% v/
v  β-mercaptoethanol) and protein concentrations were
determined using the Bradford method (Bradford Rea-
gent, Sigma). Proteins homogenates (3 μg per lane) were
separated on a 12.5% polyacrylamide SDS-PAGE and
transferred on nitrocellulose membrane for western blot-
ting. Membrane blocking, antibody dilution and washes
were performed in the gelatin-western buffer (20 mM Tris-
HCl pH 7.3, 0,9% w/v NaCl, 1% v/v gelatin from cold
water fish (Sigma-Aldrich, Taufkirchen), 0,1% v/v Tween-
20). Primary antibodies were applied on the membrane
overnight at 4°C at the following concentration: goat anti-
DCX C18 1:1000 (Santa Cruz, California, USA), goat anti-
EGFP 1:1000 (Rockland, Gilbertsville, PA, USA) and rab-
bit anti-actin 1:5000 (Sigma-Aldrich, Taufkirchen). Perox-
idase-conjugated donkey anti-goat (Sigma-Aldrich) and
peroxidase-conjugated donkey anti-rabbit antibodies
were applied on membranes for 2 hours at room temper-
ature. Following extensive washes, immuno-complexes
were revealed using ECL-Plus Western Blotting Detection
System (Amersham-Pharmacia, Freiburg) and photo-
graphic emulsion (Hyperfilm, Amersham-Pharmacia).
Immunocytochemistry
Cells were fixed for 30 minutes in phosphate-buffered 4%
paraformaldehyde. Following washes, cells were blocked
for 1 hour with gelatin-histology buffer (100 mM Tris-HCl
pH 7.4, 150 mM NaCl, 1% bovine serum albumin, 0.2%
gelatin from cold water fish (Sigma) and 0.1% Triton
X100). Antibody dilutions and subsequent washes with
also performed in this gelatin-histology buffer. Incuba-
tion with the primary antibodies was performed overnight
at 4°C at the following dilutions: mouse anti-A2B5 1:200
(Chemicon), mouse anti-βIII-tubulin 1:500 (Promega),
goat anti-Doublecortin C18 1:250 (Santa Cruz Biotech-
nology), rabbit anti-GFAP 1:1000 (Dako), mouse anti-
Map2ab 1:250 (Sigma), rabbit anti-nestin 1:200 (Chemi-
con), mouse anti-NeuN 1:500 (Chemicon), rabbit anti-
NG2 1:200 (Chemicon). Fluorochrome-conjugated don-
key secondary antibodies diluted 1:500 were applied for 2
hours at room temperature (Alexa Fluor, Molecular
Probes). Nuclear staining was obtained using 0.25 μg/ul
of DAPI before mounting in Prolong Gold antifade rea-
gent (Molecular Probes)
Abbreviations
bHLH, basic helix-loop-helix; DCX, doublecortin; EGFP,
enhanced green fluorescent protein; NGF, nerve growth
factor; Ngn2, neurogenin 2; NSE, neuron-specific enolase;
RA, retinoic acid.
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